chr7-73840474-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152559.3(METTL27):c.328G>A(p.Gly110Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000197 in 1,608,480 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00020 ( 1 hom. )
Consequence
METTL27
NM_152559.3 missense
NM_152559.3 missense
Scores
7
11
Clinical Significance
Conservation
PhyloP100: 1.28
Genes affected
METTL27 (HGNC:19068): (methyltransferase like 27) This gene encodes a protein belonging to ubiE/COQ5 methyltransferase family. The gene is deleted in Williams syndrome, a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.22-q11.23. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10666022).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
METTL27 | NM_152559.3 | c.328G>A | p.Gly110Ser | missense_variant | 4/6 | ENST00000297873.9 | NP_689772.2 | |
METTL27 | XM_017011777.2 | c.328G>A | p.Gly110Ser | missense_variant | 4/6 | XP_016867266.1 | ||
METTL27 | XM_017011778.2 | c.328G>A | p.Gly110Ser | missense_variant | 4/6 | XP_016867267.1 | ||
METTL27 | XR_001744563.2 | n.359G>A | non_coding_transcript_exon_variant | 4/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
METTL27 | ENST00000297873.9 | c.328G>A | p.Gly110Ser | missense_variant | 4/6 | 1 | NM_152559.3 | ENSP00000297873.4 | ||
METTL27 | ENST00000458679.5 | n.253-354G>A | intron_variant | 4 | ENSP00000398533.1 | |||||
METTL27 | ENST00000493174.1 | n.284-354G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 151982Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
30
AN:
151982
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000297 AC: 70AN: 235884Hom.: 0 AF XY: 0.000279 AC XY: 36AN XY: 129176
GnomAD3 exomes
AF:
AC:
70
AN:
235884
Hom.:
AF XY:
AC XY:
36
AN XY:
129176
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000197 AC: 287AN: 1456498Hom.: 1 Cov.: 31 AF XY: 0.000200 AC XY: 145AN XY: 724264
GnomAD4 exome
AF:
AC:
287
AN:
1456498
Hom.:
Cov.:
31
AF XY:
AC XY:
145
AN XY:
724264
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 30AN: 151982Hom.: 0 Cov.: 31 AF XY: 0.000162 AC XY: 12AN XY: 74226
GnomAD4 genome
AF:
AC:
30
AN:
151982
Hom.:
Cov.:
31
AF XY:
AC XY:
12
AN XY:
74226
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.328G>A (p.G110S) alteration is located in exon 4 (coding exon 3) of the WBSCR27 gene. This alteration results from a G to A substitution at nucleotide position 328, causing the glycine (G) at amino acid position 110 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Benign
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at